Cargando…

Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables

OBJECTIVE: p73 and p63 are two structural and functional homologs of p53, and their biological functions in cancer progression have attracted attention due to the presence of variants generated by genetic polymorphisms. Recently, three single nucleotide polymorphisms (SNPs) in the p63 and p73 genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Xiao, Zhang, Ning, Yin, Yongshuo, Kong, Beihua, Yang, Qifeng, Han, Zhiyan, Yang, Xingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542002/
https://www.ncbi.nlm.nih.gov/pubmed/23095717
http://dx.doi.org/10.1186/1756-9966-31-89
_version_ 1782255429674336256
author Guan, Xiao
Zhang, Ning
Yin, Yongshuo
Kong, Beihua
Yang, Qifeng
Han, Zhiyan
Yang, Xingsheng
author_facet Guan, Xiao
Zhang, Ning
Yin, Yongshuo
Kong, Beihua
Yang, Qifeng
Han, Zhiyan
Yang, Xingsheng
author_sort Guan, Xiao
collection PubMed
description OBJECTIVE: p73 and p63 are two structural and functional homologs of p53, and their biological functions in cancer progression have attracted attention due to the presence of variants generated by genetic polymorphisms. Recently, three single nucleotide polymorphisms (SNPs) in the p63 and p73 genes have been associated with female reproduction. In the present study, we aimed to evaluate the relationship between these SNPs and ovarian cancer susceptibility and clinical pathology. METHODS: We genotyped the p63 (rs873330 [Genbank, refSNP ID] T > C [T: original base, C: mutant base]) and p73 (rs4648551 G > A and rs6695978 G > A) SNPs in ovarian cancers and healthy controls and analyzed the distributions of genotype frequencies to evaluate the association of the genotypes with the risk of ovarian cancer and the clinicopathological characteristics. Logistic regression models were applied in statistical analyses. RESULTS: Our research revealed that p73 rs6695978 G > A was significantly associated with ovarian cancer patients. Women with the A allele were at increased risk of ovarian cancer compared to carriers of the G allele (OR = 1.55; 95% CI:1.07–2.19; P = 0.003). Meanwhile, the at-risk A allele was positively related with the occurrence of mucinous ovarian cancer (OR = 3.48; 95% CI:1.15-6.83; P = 0.001), low degree of differentiation (OR = 1.87; 95% CI:1.03-3.47; P = 0.003), lymph node metastasis (OR = 1.69; 95% CI: 1.14-2.75; P = 0.010) and estrogen receptor positive (OR = 2.72; 95% CI: 1.38-4.81; P = 0.002). However, we were unable to find any associations of the polymorphisms in another two SNPs (rs4648551 G > A, rs873330 T > C) with ovarian cancer risk and clinicopathological parameters. CONCLUSIONS: The p73 rs6695978 G > A polymorphism will serve as a modifier of ovarian cancer susceptibility and prognosis. Further investigations with large sample sizes and of the mechanistic relevance of p73 polymorphism will be warranted
format Online
Article
Text
id pubmed-3542002
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35420022013-01-11 Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables Guan, Xiao Zhang, Ning Yin, Yongshuo Kong, Beihua Yang, Qifeng Han, Zhiyan Yang, Xingsheng J Exp Clin Cancer Res Research OBJECTIVE: p73 and p63 are two structural and functional homologs of p53, and their biological functions in cancer progression have attracted attention due to the presence of variants generated by genetic polymorphisms. Recently, three single nucleotide polymorphisms (SNPs) in the p63 and p73 genes have been associated with female reproduction. In the present study, we aimed to evaluate the relationship between these SNPs and ovarian cancer susceptibility and clinical pathology. METHODS: We genotyped the p63 (rs873330 [Genbank, refSNP ID] T > C [T: original base, C: mutant base]) and p73 (rs4648551 G > A and rs6695978 G > A) SNPs in ovarian cancers and healthy controls and analyzed the distributions of genotype frequencies to evaluate the association of the genotypes with the risk of ovarian cancer and the clinicopathological characteristics. Logistic regression models were applied in statistical analyses. RESULTS: Our research revealed that p73 rs6695978 G > A was significantly associated with ovarian cancer patients. Women with the A allele were at increased risk of ovarian cancer compared to carriers of the G allele (OR = 1.55; 95% CI:1.07–2.19; P = 0.003). Meanwhile, the at-risk A allele was positively related with the occurrence of mucinous ovarian cancer (OR = 3.48; 95% CI:1.15-6.83; P = 0.001), low degree of differentiation (OR = 1.87; 95% CI:1.03-3.47; P = 0.003), lymph node metastasis (OR = 1.69; 95% CI: 1.14-2.75; P = 0.010) and estrogen receptor positive (OR = 2.72; 95% CI: 1.38-4.81; P = 0.002). However, we were unable to find any associations of the polymorphisms in another two SNPs (rs4648551 G > A, rs873330 T > C) with ovarian cancer risk and clinicopathological parameters. CONCLUSIONS: The p73 rs6695978 G > A polymorphism will serve as a modifier of ovarian cancer susceptibility and prognosis. Further investigations with large sample sizes and of the mechanistic relevance of p73 polymorphism will be warranted BioMed Central 2012-10-24 /pmc/articles/PMC3542002/ /pubmed/23095717 http://dx.doi.org/10.1186/1756-9966-31-89 Text en Copyright ©2012 Guan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Guan, Xiao
Zhang, Ning
Yin, Yongshuo
Kong, Beihua
Yang, Qifeng
Han, Zhiyan
Yang, Xingsheng
Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title_full Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title_fullStr Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title_full_unstemmed Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title_short Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
title_sort polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542002/
https://www.ncbi.nlm.nih.gov/pubmed/23095717
http://dx.doi.org/10.1186/1756-9966-31-89
work_keys_str_mv AT guanxiao polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT zhangning polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT yinyongshuo polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT kongbeihua polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT yangqifeng polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT hanzhiyan polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables
AT yangxingsheng polymorphismsinthep63andp73genesareassociatedwithovariancancerriskandclinicopathologicalvariables